Varghese, Della
Cruz, Giovanna I. http://orcid.org/0000-0001-7422-6043
Johanson, Colden
Toland, Liz
Miranda, Miguel
Faherty, Eleanor C.
Harland, David
Kaplan, Henry G.
Funding for this research was provided by:
AstraZeneca PLC
Daiichi Sankyo Company
Article History
Received: 17 November 2023
Accepted: 16 February 2024
First Online: 25 March 2024
Declarations
:
: DV, MM, DH are employees of AstraZeneca at time of manuscript development. ECF was an employee of AstraZeneca during the study period and is an employee of Daiichi Sankyo during the time of this manuscript development. GIC is employed by Syapse and CJ and LT were employed by Syapse at the time that this study was conducted. HK has received consulting fees from Syapse and also owns stock in Abbott Labs, Amgen, Bristol Myers Squibb, Merck, and Becton Dickinson. HK is an employee of the Swedish Cancer Institute.
: This study was a retrospective analysis of secondary data, and therefore, ethics approval was not required. All data were de-identified and handled in compliance with HIPAA requirements.